| CXSL2400603 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-11 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2101064 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-07-06 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101650 | BPI-371153胶囊 | BPI-371153 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-11-12 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2300015 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2023-01-20 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101019 | BPI-16350 胶囊 | BPI-16350 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-04-07 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200864 | BPI-452080 片 | BPI-452080 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-11-03 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2300495 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2023-05-09 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2400013 | BPI-221351片 | BPI-221351 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-01-05 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200060 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(2.4) | New Drug Application | 2022-01-28 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2400677 | CFT8919胶囊 | CFT-8919 | Capsule | Chemical Drugs(1) | New Drug Application | 2024-07-10 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101238 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-06-28 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2300016 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2023-01-20 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200896 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2022-11-15 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXSL2300322 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2023-05-09 | | Betta Pharmaceuticals Co Ltd | | | view |
| CYHB2101569 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-07-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2400011 | BPI-520105片 | BPI-520105 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-01-05 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2101028 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(2.4) | New Drug Application | 2021-07-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXSB2200001 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | Supplementary Application | 2022-01-07 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101239 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-06-28 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200963 | BPI-472372片 | BPI-472372 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-12-29 | | Betta Pharmaceuticals Co Ltd | | | view |
